Who invested in Kalbe Genexine Biologics?
Kalbe Genexine Biologics's investors include General Atlantic.
Who invested in Kalbe Genexine Biologics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$55Mraised across 1 round since 2021, from 1 source
- Latest round
- Growth, $55MJan 2021
- Investors
- 1
The rounds
- Jan 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kalbe Genexine Biologics
How much has Kalbe Genexine Biologics raised?
Kalbe Genexine Biologics has raised $55M across 1 round since 2021.
When did Kalbe Genexine Biologics last raise?
Kalbe Genexine Biologics's most recent round was a Growth of $55M in Jan 2021.
What was Kalbe Genexine Biologics's biggest round?
Its most recent round, $55M in Jan 2021, is also its largest on record.
Who backed Kalbe Genexine Biologics first?
Kalbe Genexine Biologics's first round on record, in Jan 2021, was backed by General Atlantic.
What stage is Kalbe Genexine Biologics at?
Kalbe Genexine Biologics's latest named round is a Growth, in Jan 2021.
Companies like Kalbe Genexine Biologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.